The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 872 Weight Management articles
Eli Lilly's Foundayo, a groundbreaking once-daily oral GLP-1 pill for weight loss, is now shipping nationwide in the US following FDA approval. Backed by the ATTAIN trials, it delivered an average 27-pound loss at the highest dose. Discover access options, pricing, and what patients need to know.
Amazon is revolutionizing access to GLP-1 weight-loss drugs by launching same-day delivery for Foundayo through Amazon Pharmacy in nearly 3,000 cities. Patients can now order with a valid prescription, check real-time availability, and get medication home-delivered faster than traditional options. This move cuts treatment barriers from prescription to doorstep.
Rosie O'Donnell, who started Mounjaro in January 2023 for diabetes management, has become a poster child for 'Mounjaro face' after shedding 10 pounds quickly. Side-by-side photos from September 2022 and October 2025 highlight sagging skin around her mouth and cheeks, with expert analysis noting a grayish hue. Despite cosmetic changes, she's embracing the weight loss benefits.
Real Housewives of Salt Lake City star Heather Gay has shared her Ozempic-assisted weight loss journey, crediting the GLP-1 injection for noticeable results after initial slow progress. Losing around 30 pounds amid social pressures from friends' transformations, she called it a 'long, overdue glow-up' thanks to modern medicine. Despite Ozempic face rumors, Gay remains open about her experience.
India's semaglutide market is heating up with more than 50 brands poised to launch post-patent. But experts warn of a measured rollout due to the drug's intricate manufacturing demands. Inside the scramble for affordable GLP-1 access in a diabetes hotspot.
Cheaper generic semaglutide is transforming access to weight loss and diabetes treatment in India, priced at just Rs750 per weekly injection. However, experts caution against 'quick-fix' use without medical oversight, highlighting risks like 40% muscle loss from lean mass. Discover clinical evidence from STEP-1 and SELECT trials and why structured care is essential.
Wegovy, Ozempic, and Mounjaro promise effortless weight loss with minimal risk, but new research uncovers deeper dangers like altered brain chemistry and loss of desire. On The Spectacle Podcast, Scott McKay and Melissa Mackenzie dive into the science, Melissa's personal story, and why lifestyle changes offer a safer path.
Novo Nordisk has won EU regulatory approval to ease cold chain requirements for Wegovy injections, marking the first GLP-1 therapy in Europe with such delivery flexibility. The change allows a 48-hour window without refrigeration from pharmacies to patients, streamlining distribution and enhancing access. This aligns with trends in direct-to-patient models and complements recent subscription programs for better affordability.
As GLP-1 drugs like Ozempic transform weight loss, biotech startup Lembas argues biopeptides can reclaim a role through food-based satiety support. CEO Shay Hillel, speaking at Future Food-Tech San Francisco, positions these short proteins as complements—not replacements—for better metabolic health. With clinical trials underway, functional foods may soon enhance GLP-1 therapy.
